JBC Focus on PI3-Kinase with Echelon

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M202473200 on April 12, 2002

J. Biol. Chem., Vol. 277, Issue 25, 22469-22474, June 21, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/25/22469    most recent
M202473200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hammet, A.
Right arrow Articles by Heierhorst, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hammet, A.
Right arrow Articles by Heierhorst, J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Posttranscriptional Regulation of the RAD5 DNA Repair Gene by the Dun1 Kinase and the Pan2-Pan3 Poly(A)-Nuclease Complex Contributes to Survival of Replication Blocks*

Andrew Hammet, Brietta L. Pike, and Jörg HeierhorstDagger

From the St. Vincent's Institute of Medical Research and Department of Medicine, St. Vincent's Hospital, The University of Melbourne, 9 Princes Street, Fitzroy, Victoria 3065, Australia

Received for publication, March 14, 2002, and in revised form, April 11, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The yeast Dun1 kinase has complex checkpoint functions including DNA damage-dependent cell cycle arrest in G2/M, transcriptional induction of repair genes, and regulation of postreplicative DNA repair pathways. Here we report that the Dun1 forkhead-associated domain interacts with the Pan3 subunit of the poly(A)-nuclease complex and that dun1pan2 and dun1pan3 double mutants are dramatically hypersensitive to replicational stress. This phenotype was independent of the function of Dun1 in regulating deoxyribonucleotide levels as it was also observed in strains lacking the ribonucleotide reductase inhibitor Sml1. dun1pan2 mutants initially arrested normally in response to replication blocks but died in the presence of persistent replication blocks with considerably delayed kinetics compared with mutants lacking the Rad53 kinase, indicating that the double mutation does not compromise the intra-S phase checkpoint. Interestingly, the RAD5 gene involved in error-free postreplication repair pathways was specifically up-regulated in dun1pan2 double mutants. Moreover, inducible overexpression of RAD5 mimicked the double mutant phenotype by hypersensitizing dun1 mutants to replication blocks. The data indicate that Dun1 and Pan2-Pan3 cooperate to regulate the stoichiometry and thereby the activity of postreplication repair complexes, suggesting that posttranscriptional mechanisms complement the transcriptional response in the regulation of gene expression by checkpoint signaling pathways in Saccharomyces cerevisiae.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Eukaryotic cells contain highly conserved checkpoint signaling pathways that prevent genomic instability by regulating the cellular response to DNA damage and replication blocks. Checkpoints involve slowing or arresting the cell cycle until the damage is repaired, the transcriptional induction of repair enzymes, and the direct activation of repair processes (1). The yeast Dun1 protein is a member of a family of protein kinases closely related to the human Chk2/HuCds1 kinase (2, 3) that is mutated in a subset of patients suffering from the Li-Fraumeni multicancer syndrome (4). These kinases are characterized by the presence of at least one FHA1 domain, a protein-protein interaction module present in more than 200 different proteins (5) that seems to specifically bind to phosphorylated amino acids (preferentially phosphothreonine) in target sequences (6-9). dun1 mutant strains have a reduced replication block/DNA damage-dependent induction of repair genes (10), a reduced cell cycle arrest function in the G2/M checkpoint (11, 12), and increased rates of spontaneous chromosome rearrangements (13, 14). The Dun1 kinase is activated through phosphorylation by checkpoint signals in a MEC1- and RAD53-dependent manner (15), and its positive effect on transcription involves the phosphorylation and inactivation of the Crt1 transcriptional repressor (16). In contrast to the cell cycle arrest function of the S phase checkpoint that is RAD53-dependent and largely DUN1-independent (12), DUN1 seems to play a much more crucial role than RAD53 in preventing gross chromosomal rearrangements (particularly de novo telomere additions to chromosome breakpoints) after spontaneous DNA replication errors during normal cell cycles, indicating that it has a specific function in regulating postreplicative DNA repair pathways (13).

In addition to the transcriptional control of gene expression, posttranscriptional mRNA modifications and mRNA decay pathways play crucial roles in the eukaryotic regulation of protein levels (17). A major posttranscriptional modification is the addition of the poly(A) tail at the 3'-end of pre-mRNAs that contributes to the regulation of protein translation (18, 19) and mRNA stability (17). In Saccharomyces cerevisiae, mRNA degradation is usually initiated by the 3' right-arrow 5' exonucleolytic digest of the poly(A) tail by a cytoplasmic mRNA deadenylase containing the Ccr4 and Caf1 proteins (20). In addition to Ccr4-Caf1, poly(A) tail length distribution is also regulated by the poly(A)-nuclease (PAN) complex, which consists of the catalytic 135-kDa Pan2 subunit with sequence motifs characteristic of RNase D-like 3' right-arrow 5' exonucleases (21) and the 72-kDa Pan3 subunit of unknown function. The primary function of PAN seems to be to "preset" poly(A) tails to message-specific lengths before or during the nucleocytoplasmic export of mRNAs (22), but it also contributes to cytoplasmic mRNA turnover as an alternative or complementing pathway to Ccr4-Caf1 (20).

Here we report that Dun1 cooperates with PAN in the regulation of RAD5 mRNA levels and cell survival in response to replicational stress. The data suggest that posttranscriptional mechanisms contribute to the regulation of gene expression by checkpoint signaling pathways.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Yeast Strains and Plasmids-- Yeast two-hybrid assays were performed in PJ69-4A (MATa, trp1-901, leu2-3,112, ura3-52, his3-200, gal4Delta , gal80Delta , LYS2::GAL1-HIS3, GAL2-ADE2, met2::GAL7-lacZ) (23). Functional experiments were performed in the BY4741 genetic background (MATa, his3Delta 1, leu2Delta 0, met15Delta 0, ura3Delta 0) (24) except for the rad53Delta sml1Delta strain (25), which was in the W303-1A background (26). BY4741 strains containing pan2 or pan3 deletions (pan2Delta ::kanMX4 or pan3Delta ::kanMX4) were obtained from Research Genetics. DUN1 was disrupted in these strains using standard PCR-based methods and LEU2 as a selectable marker. Double and triple mutants with sml1Delta were obtained by mating dun1Delta pan2Delta or dun1Delta pan3Delta strains with a sml1Delta strain in the BY4742 background (MATalpha , his3Delta 1, leu2Delta 0, lys2Delta 0, ura3Delta 0, sml1Delta ::kanMX4) followed by sporulation and tetrad dissection. For generation of the PAN3-HA allele, a hemagglutinin (HA) tag was introduced at the 3'-end of the coding sequence by PCR and pop-in/pop-out selection and was confirmed by PCR and immunoprecipitation/immunoblot analysis. For overexpression experiments, RAD5 residues corresponding to the full-length cDNA were generated by PCR and cloned into p416GAL1 (27).

Yeast Two-hybrid Assays-- Randomly primed yeast cDNA was synthesized using standard conditions, cloned into pGAD GH (CLONTECH) using EcoRI adaptors (Promega), and transformed into the Escherichia coli strain XL10-Gold (Stratagene). The library contained ~110,000 independent clones. The Dun1 FHA domain (residues 19-159) cloned into pAS2 was used as bait to screen the library for FHA-interacting proteins. Interacting clones were selected on plates lacking Trp, Leu, and His and containing 2 mM 3-aminotriazole. Positive clones were isolated after 5 days, patched onto identical plates also lacking adenine as an additional reporter, and grouped by restriction enzyme mapping and cDNA sequence analysis. Clones were also tested for beta -galactosidase activity of liquid cultures as a third reporter. Color development was monitored by absorbance measurements at 420 nm and corrected for protein levels by Bradford assay. To confirm the interaction, the original interacting Pan3 clone as well as various fragments and a full-length cDNA generated by PCR were cotransformed with pAS2-Dun1FHA or empty pAS2.

HU and MMS Sensitivity Assays-- For plate assays, 2 µl of 10-fold serial dilutions of yeast cultures (starting A600 = 0.5) were spotted onto yeast extract/peptone/dextrose (YPD) plates containing 100 mM HU and incubated for 4 days at 30 °C. Similar experiments were performed with yeast strains transformed with p416GAL1 or p416GAL1-RAD5 plasmids that were plated on synthetic medium lacking uracil and containing either 2% sucrose or 2% sucrose plus 4% galactose. For solution assays, 0.2 M HU was added to log phase yeast cultures in YPD at 30 °C. Aliquots taken immediately before HU addition and at various intervals over a 24-h time course were plated on YPD. Plates were incubated at 30 °C for 3 days before visible colonies were counted. Survival is expressed as the percentage of colony-forming (=viable) cells at each time point relative to colony formation before HU addition. MMS sensitivity experiments were performed similarly except that MMS was added at 0.02, 0.03, and 0.04% for 4 h.

RNA Methods-- Total RNA isolation and Northern blot analyses were performed using standard methods as described previously (28). RNR3 (nucleotide residues 870-2208) and RAD5 (residues 2747-3274) probes were generated by PCR from genomic DNA and cloned into pGEM-T (Promega). For poly(A) tail length distribution analyses, 1 µg of total RNA was end-labeled with 5'-[32P]pCp using T4 RNA ligase, RNase A-digested as described (29), and separated by 7 M urea, 6% polyacrylamide gel electrophoresis. For DNA array analysis, 1 µg of poly(A)+ RNA from HU-treated strains was reverse-transcribed using oligo(dT)12-18 primer and avian myeloblastosis virus reverse transcriptase in the presence of 100 µCi of [alpha 32P]dCTP and hybridized to a set of Yeast GeneFilters cDNA microarrays (Research Genetics) at 42 °C. Filters were exposed for 4-6 days, stripped according to the manufacturer's recommendations, and rehybridized. The identity of the RAD5 spot was confirmed by rehybridizing the DNA array with the RAD5 cDNA probe. Autoradiographs were exposed to PhosphorImager screens followed by quantitative analysis using Molecular Dynamics software.

Other Methods-- For cell cycle analyses, 1-ml aliquots of yeast cultures were fixed in 70% ethanol. 200 µl of cells were washed with 50 mM sodium citrate, pH 7, and incubated overnight with 0.1 mg/ml RNase A in 50 mM sodium citrate at 37 °C. Cells were sonicated, treated with 4 µg/ml propidium iodide, and analyzed using a Becton Dickinson FACScan and CellQuest software. Rad53 immunoblots using a goat anti-Rad53 antibody (Santa Cruz Biotechnology) and enhanced chemiluminescence reagents (Amersham Biosciences) were performed as described previously (25).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Interaction of the Dun1 FHA Domain with Pan3-- The Dun1 FHA domain contains ~137 amino acid residues (28) and can bind to a phosphorylated model peptide in vitro (25). To understand the physiological function of this domain, we performed a yeast two-hybrid screen to identify interacting yeast proteins. In this screen, we isolated two identical clones that contained residues 2-237 of Pan3. This Pan3 construct supported growth on reporter plates lacking histidine and adenine only when cotransformed with the Dun1 FHA domain construct (Fig. 1) but not with the corresponding empty vector or the Chk2 FHA domain (data not shown). Similar results were also obtained with a full-length Pan3 construct (which had a 6-fold higher activity than the original clone in beta -galactosidase induction as a third reporter gene; data not shown) but not several truncated constructs (Fig. 1), indicating that this interaction depends on the proper three-dimensional fold of the Pan3 N terminus. To confirm this interaction, we introduced a HA tag into the chromosomal PAN3 gene for coimmunoprecipitation experiments. However, Pan3-HA could only be detected in immunoprecipitations from large culture volumes (0.25-1 liter in log phase), and we failed to detect Dun1 in Pan3-HA immunoprecipitates from untreated cultures or after treatment with the replication-blocking agent HU or the DNA-damaging agent MMS (data not shown). This indicates that the interaction between Dun1 and Pan3 involves only a small fraction of these proteins or that it is either weak or very transient, reminiscent of the recently reported two-hybrid interaction between the Schizosaccharomyces pombe Cds1 FHA domain and the replication checkpoint protein Mrc1 (30).


View larger version (56K):
[in this window]
[in a new window]
 
Fig. 1.   Yeast two-hybrid analysis of the Dun1 FHA-Pan3 interaction. Yeast strains cotransformed with the pAS2-Dun1FHA (residues 19-159) bait vector and pGAD GH empty vector or Pan3 constructs as indicated were streaked at similar cell densities on plates lacking Trp and Leu (-WL, left) or plates lacking Trp, Leu, His, and adenine (-WLHAde, right).

Synthetic Lethality of dun1 and pan2/pan3 in Response to Replicational Stress-- dun1 mutants grow poorly on plates containing HU, an inhibitor of ribonucleotide reductase (RNR) that causes replication blocks due to dNTP depletion (10, 26). To independently evaluate the interaction of Dun1 with Pan3, we used a genetic approach to investigate whether the PAN complex modifies this HU-dependent growth defect. Deletion of the PAN3 gene or the gene for the catalytic Pan2 subunit had no gross effect on cell growth in an otherwise wild type background or in the dun1Delta background on control plates (Fig. 2A, top panel). Deletion of either PAN2 or PAN3 alone also did not affect cell growth in the presence of 100 mM HU (Fig. 2A, bottom panel). However, compared with the single dun1Delta mutation the growth defect on HU plates was increased by >100-fold in dun1Delta pan2Delta and dun1Delta pan3Delta double mutant strains (Fig. 2A, bottom panel). The inability of the double mutants to form colonies on HU plates could reflect slower cell growth or increased lethality. We therefore analyzed cell viability in the presence of 200 mM HU over a 24-h time course. In this experiment (Fig. 2B), viable wild type cells as well as pan2Delta mutants increased in number despite the presence of HU. dun1Delta mutants failed to proliferate, but >90% of cells remained viable even after 24 h in 200 mM HU (Fig. 2B). In contrast, viability of dun1Delta pan2Delta double mutants decreased after 8 h, and after 24 h only ~7% of cells were able to form colonies when plated on normal medium (Fig. 2B). As the majority of synthetic lethal interactions occur between genes that act in a common biochemical pathway (31), the more than additive defect of dun1Delta and pan2Delta or pan3Delta in response to replication blocks supports the interaction of the Dun1 FHA domain with Pan3 observed in the two-hybrid screen.


View larger version (59K):
[in this window]
[in a new window]
 
Fig. 2.   Genetic interaction of DUN1 and PAN2/PAN3 pathways. A, drop test analysis of 2 µl of serial 10-fold dilutions (starting A600 = 0.5) of the yeast strains indicated above spotted onto YPD plates (top) and YPD plates containing 100 mM HU (bottom) and incubated for 4 days at 30 °C. B, viability time course analysis of yeast strains as indicated in liquid YPD cultures containing 200 mM HU at 30 °C. C, drop test analysis as in A in yeast strains containing the sml1Delta mutation. D, MMS sensitivity. Liquid cultures of the indicated strains were incubated in YPD medium containing 0.02, 0.03, or 0.04% MMS for 4 h before plating on YPD plates for viability analysis. WT, wild type.

The dun1pan2/3 Phenotype Is Independent of RNR Regulation and the Intra-S Phase Checkpoint-- dun1 mutants are severely compromised but not entirely deficient in up-regulating RNR genes in response to HU treatment (10). We therefore tested whether further reduced RNR levels could cause the increased HU sensitivity of the double mutants. However, Northern blot analysis demonstrated that HU-induced RNR3 mRNA levels in the dun1Delta pan2Delta strain were similar to those in the dun1Delta strain (Fig. 3A). We also tested the effect of the sml1Delta mutation on the double mutant strains. Sml1 inhibits RNR activity, and sml1Delta results in 2.5-fold higher dNTP levels and extragenic suppression of several dun1 phenotypes (26). However, although sml1Delta improved cell growth on HU plates, it did not alleviate the HU hypersensitivity of the dun1Delta pan2Delta and dun1Delta pan3Delta mutants relative to dun1Delta (Fig. 2C).


View larger version (37K):
[in this window]
[in a new window]
 
Fig. 3.   Transcriptional response, checkpoint signaling, and cell cycle analysis in dun1Delta pan2Delta double mutants and control strains. A, Northern blot analysis of 15 µg of total RNA/lane probed for RNR3 and 18 S RNA. Genotypes and treatments (-, control; H, 200 mM HU; M, 0.1% MMS for 3 h) are indicated above. B, flow cytometry of yeast strains indicated above at the time points after HU addition (200 mM) shown on the left. Stippled lines indicate cells with 1n and 2n DNA content. C, Rad53 immunoblot analysis. Cultures were treated for 2 h as indicated in A. WT, wild type.

Another explanation for the increased lethality could be an insufficient cell cycle arrest function of the S phase checkpoint. We therefore analyzed cells from HU time course experiments by flow cytometry. Fig. 3B shows that all strains initially synchronized in S phase after HU addition and that this arrest was maintained in the dun1Delta pan2Delta strain for about 6 h. However, while wild type and pan2Delta cells reassumed a normal cell cycle profile after 24 h (presumably due to RNR up-regulation to generate sufficient dNTPs), analysis of the dun1Delta pan2Delta strain revealed a dramatic accumulation of cells with <1n DNA content after 12 and 24 h, consistent with increased genome instability as a cause of the HU-dependent lethality. Rad53 plays a central role in arresting the cell cycle in response to replication blocks, and Fig. 2B shows that the lethality of dun1Delta pan2Delta double mutants occurred with a considerable delay compared with rad53Delta cells (in a non-isogenic sml1Delta background). Likewise Rad53 activation by hyperphosphorylation (which can be detected as slower migrating bands in immunoblots; Ref. 32) in response to HU treatment was uncompromised in the dun1Delta pan2Delta strain (Fig. 3C).

Taken together these results demonstrate that the increased replication block sensitivity of the double mutant is independent of dNTP levels and the S phase cell cycle arrest function. Finally, in contrast to the HU hypersensitivity, dun1Delta pan2Delta and dun1Delta pan3Delta double mutants had no increased DNA damage sensitivity after treatment with MMS (Fig. 2D), indicating that the genetic interaction of DUN1 and PAN2/3 is specifically required for the survival of replicative DNA damage.

Regulation of RAD5 mRNA Levels by Dun1 and PAN-- To test whether poly(A) tails may be a checkpoint target in vivo, we analyzed poly(A) tail length distribution profiles in response to replication blocks and DNA damage in wild type, dun1Delta , pan2Delta , and dun1Delta pan2Delta strains (Fig. 4A). In these experiments, deletion of PAN2 increased the maximal length of poly(A) tails by ~20 bases, similar to previous reports (22). Interestingly, HU treatment caused a slight decrease in the maximal poly(A) tail length in all strains, whereas DNA damage by MMS treatment caused a noticeable increase (particularly in dun1Delta pan2Delta ) of the maximal length of poly(A) tails (Fig. 4A). While these data are consistent with the modulation of poly(A) tail length distribution profiles by checkpoint signals, we cannot exclude the possibility that these are secondary effects of synchronizing cells in S phase (HU) with a corresponding shift in gene expression profiles or possible slowing of nucleocytoplasmic export of mRNAs that could result in longer poly(A) tails (33). Moreover, the overall effects were still maintained in the pan2Delta and double mutant strains. Therefore, these changes are either independent of the Pan2-Pan3 complex or compensated by an alternative mRNA deadenylase, for example the Ccr4-Caf1 complex (20). Importantly, the overall poly(A) tail length profile after HU treatment was essentially identical in the pan2Delta strain (which remains viable after replication blocks) and the dun1Delta pan2Delta strain (for which replication blocks are lethal), indicating that the increased lethality of the dun1Delta pan2Delta double mutant is not simply the result of globally deregulated poly(A) tail length profiles.


View larger version (56K):
[in this window]
[in a new window]
 
Fig. 4.   RAD5 up-regulation in the dun1Delta pan2Delta strain. A, poly(A) tail length distribution profiles in control (-), HU-treated (H), and MMS-treated (M) wild type (WT), pan2Delta , dun1Delta , and dun1Delta pan2Delta strains. Positions of markers (bases) are indicated on the left. B, DNA array analysis. Autoradiograph of an area containing >400 open reading frames subsequently hybridized with probes from poly(A)+ RNA of pan2Delta , dun1Delta pan2Delta , and dun1Delta strains treated for 3 h with 150 mM HU. Normalized to an intermediate intensity spot (YOR234c, open arrowhead, 1 arbitrary unit), the RAD5 signal (circled) was increased by 65-130-fold in the double mutant strain (10.39 arbitrary units) relative to the dun1Delta (0.16 arbitrary units) and pan2Delta (0.08 arbitrary units) strains. Other spots differed only marginally between these strains (YOL040c, near the lower corner of the open arrowhead: dun1Delta pan2Delta  = 3.42, pan2Delta  = 4.43, dun1Delta  = 4.62 arbitrary units; YML039w, filled arrowhead, upper left corner: dun1Delta pan2Delta  = 8.74, pan2Delta  = 7.74, dun1Delta  = 7.37 arbitrary units). C, DNA array analysis of other members (boxed) of the RAD6 epistasis group. D, Northern blot analysis of total RNA isolated from control (-), HU-treated (H), or MMS-treated (M) strains indicated above probed for RAD5 and 18 S RNA as a loading control. The graph shows the mean of normalized RAD5/18 S ratios based on quantitative phosphorimaging analysis. Error bars indicate the range of two independent experiments.

To test whether the increased replication block sensitivity of the dun1Delta pan2Delta strain may instead be caused by a specific effect on few mRNAs, we analyzed gene expression profiles by subsequent hybridizations of a yeast DNA array (containing 6144 of the 6275 annotated open reading frames) using radiolabeled reverse-transcribed poly(A)+ RNA probes of HU-treated pan2Delta , dun1Delta pan2Delta , and dun1Delta strains. Surprisingly, we found only a single major change in the dun1Delta pan2Delta double mutant (Fig. 4B, circled), indicating a >60-fold up-regulation of RAD5, a gene involved in postreplicative DNA repair (34, 35). Other spots of approximately equal intensity in the double mutant were unaffected in both respective single mutants (Fig. 4B, filled arrowheads). RAD18, RAD6, UBC13, and MMS2, which share common DNA damage-inducible transcriptional control elements (36) and are epistatic with RAD5 (34, 35), were not concomitantly up-regulated in the double mutant strain (Fig. 4C), suggesting that RAD5 up-regulation is not simply a secondary change resulting from massive DNA damage. Up-regulation of RAD5 in dun1Delta pan2Delta relative to single mutants and wild type strains was confirmed in independent Northern blot experiments of total RNA samples (Fig. 4D), although in these experiments RAD5 mRNA levels were elevated only by about 2-fold relative to the other similarly treated strains. This discrepancy is reminiscent of results recently reported for COX17 mRNA levels in pufDelta strains (37) where differences between array experiments (using poly(A)+ RNA) and Northern blot analyses (using total RNA) could be attributed to strain-specific poly(A) tail length differences and overrepresentation of longer poly(A) tail-containing mRNAs in poly(A)+ RNA preparations.

Up-regulation of RAD5 mRNA Impairs dun1Delta Survival of Replicational Stress-- Regardless of the quantitative discrepancy between the Northern and array analyses, the experiments described above suggested that up-regulation of RAD5 gene expression could be the molecular mechanism responsible for the increased replication block sensitivity of dun1pan2/3 double mutants. To test this hypothesis, we tested whether ectopic overexpression of RAD5 could mimic the HU-hypersensitizing effect of pan2Delta in the dun1Delta background. For this purpose, the various yeast strains were transformed with a galactose-inducible RAD5 plasmid (under control of the GAL1 promoter) as well as the corresponding empty vector control and tested for viability on galactose-containing HU plates. Relative to the vector control, RAD5 overexpression markedly reduced the viability of dun1Delta and dun1Delta pan2Delta strains but had only a modest effect on wild type and pan2Delta strains on HU plates (Fig. 5) and had no effect on control plates lacking HU or galactose (Fig. 5). Interestingly RAD5 overexpression under these conditions had a more dramatic effect than the pan2 deletion on dun1Delta viability. This is most likely the result of much higher RAD5 mRNA levels achieved from the GAL1 promoter compared with the endogenous mRNA that was confirmed by Northern blot analysis (data not shown). Therefore, this experiment demonstrates that elevated RAD5 mRNA levels are sufficient to hypersensitize dun1Delta strains to replicational stress and supports the conclusion that elevated RAD5 mRNA levels are the reason for the increased HU-dependent lethality of the dun1Delta pan2Delta double mutant.


View larger version (44K):
[in this window]
[in a new window]
 
Fig. 5.   RAD5 overexpression hypersensitizes dun1 mutants to replicational stress. The indicated strains were transformed with p416GAL1-RAD5 or the p416GAL1 empty vector and plated as a series of 10-fold dilutions on synthetic medium lacking uracil and containing 2% sucrose (left panels) or 2% sucrose plus 4% galactose (right panels) in the absence (-) or presence of 100 mM HU. WT, wild type.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

DUN1 plays a crucial role in preventing gross chromosomal rearrangements resulting from inappropriate repair pathways of spontaneous replicative DNA damage even in the absence of exogenous DNA-damaging or replication-blocking agents (13). The data presented here indicate that the regulation of RAD5 mRNA levels by Dun1 in concert with PAN contributes to the function of DUN1 in maintaining genome stability. dun1Delta pan2Delta cells remain in S phase for considerable time (Fig. 3B), activate Rad53 as a key player in the intra-S checkpoint normally (Fig. 3C), and die after replication blocks with considerably delayed kinetics compared with rad53Delta cells (Fig. 2B). At the same time, expression of the RAD5 gene, which plays a role in postreplicative DNA repair (35), is specifically deregulated (Fig. 4) and sufficient to cause HU-dependent lethality in the dun1Delta background (Fig. 5), while the accumulation of cells with aberrant DNA contents in flow cytometry profiles (Fig. 3B) coincides temporally with the reduced viability in survival curves (Fig. 2B). The most likely explanation for the dun1Delta pan2Delta phenotype is, therefore, that these cells arrest normally in S phase while replicative DNA damage persists but that this damage is inappropriately repaired, which removes the checkpoint signal, allowing for subsequent cell division with loss of genetic material and concomitantly increased lethality.

Interestingly, DUN1 has recently been indirectly linked to regulation of the RAD6 epistasis group of which RAD5 is a member (38). Rad5 is a RING finger domain protein that mediates the interaction of the Lys-63-specific ubiquitin ligases Ubc13 and Mms2 with Rad18 and the Lys-48-specific ubiquitin ligase Rad6 (35). This heteromeric complex has been proposed to generate a signal that activates pathways for the repair of DNA double strand breaks by homologous recombination (i.e. "error-free") instead of non-homologous end joining (i.e. "error-prone") (34-36). The same surfaces involved in the heteromeric interaction of Rad5 and Rad18 can also mediate homodimerization of the respective subunits and thereby dissociate the pentamer into Rad5-Ubc13-Mms2 and Rad6-Rad18 subcomplexes, which may generate a Rad6-dependent signal to activate an error-prone subpathway (35). According to this model, increased Rad5 protein levels in the dun1Delta pan2Delta strain could indeed shift the equilibrium away from the heteromeric complex toward an error-prone postreplicative DNA repair pathway that causes the increased lethality (Fig. 6). This pathway seems to be particularly critical in the absence of DUN1 as RAD5 overexpression alone had only a subtle effect on replicational stress survival of wild type or pan2Delta strains (Fig. 5). This is conceivable given that DUN1 has several additional DNA damage repair functions, e.g. transcriptional induction of repair enzymes (16) and direct regulation of repair proteins such as Rad55 (39), which may render dun1Delta mutants more sensitive to deleterious effects of either pan2/3 deletion or RAD5 overexpression.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 6.   Model for the interaction of Dun1 and PAN pathways. Dun1 interacts transiently (stippled line) with Pan2-Pan3, which may act as a scaffold for Dun1 to access and activate the Ccr4-Caf1 deadenylase complex. Pan2-Pan3 and Ccr4-Caf1 are involved in regulating RAD5 mRNA stability. Increased Rad5 levels in the dun1Delta pan2Delta strain are unfavorable for the formation of a heteromeric complex of the RING finger proteins and ubiquitin ligases Rad5, Rad18, Rad6, Ubc13, and Mms2 required for error-free postreplicative DNA repair pathways. This way the equilibrium shifts in favor of error-prone repair pathways.

As synthetic lethality is usually a property of genes whose products interact in a common biochemical pathway (31), the simplest interpretation of our data is that Dun1 and PAN interact at the posttranscriptional level to regulate RAD5 gene expression. While the two-hybrid data indicate that Dun1 interacts directly with Pan3, a key question remaining to be answered is whether PAN activity is regulated by Dun1 in response to replication blocks. Given the synthetic effect of the two genes, it is quite possible that Dun1 does not directly regulate PAN but another enzyme with a similar function, e.g. Ccr4-Caf1. In this scenario (Fig. 6), PAN would constitutively regulate RAD5 mRNA levels, whereas Ccr4-Caf1 would be strictly Dun1-dependent and therefore compensate for the loss of PAN as long as DUN1 is present. Ccr4-Caf1 has multiple functions as an mRNA deadenylase (20) and as part of the CCR4-NOT complex in control of transcriptional initiation and elongation (40). Tucker et al. (20) have suggested that one possible explanation for linking the cytoplasmic Ccr4-Caf1 deadenylase to the transcriptional machinery is that it needs to be cotranscriptionally loaded onto messenger ribonucleoprotein complexes. If this is so, it would transiently be in a complex with PAN during the initial trimming of the poly(A) tail. In this context, Pan3 binding by the Dun1 FHA domain could act as a transient scaffold to bring the kinase domain in contact with Ccr4-Caf1 to phosphorylate it and regulate its substrate specificity before export to the cytoplasm. Interestingly, Caf1 (also known as Pop2) has recently been shown to be regulated by phosphorylation in response to diauxic shifts by the Yak1 kinase, but it is unclear whether this affects its deadenylase function (41). An important goal of future studies will be to elucidate the precise molecular mechanism by which Dun1 contributes to the regulation of RAD5 mRNA stability.

Transcriptional control of gene expression (1) and cotranscriptional regulation of mRNA 3'-end processing and polyadenylation reactions (42) are established components of cell cycle checkpoints. Our results indicate that posttranscriptional mechanisms involving poly(A) tail length control are an additional checkpoint target in the regulation of gene expression. The Pan2-Pan3 and Ccr4-Caf1 poly(A)-exonucleases, the Dun1 kinase, and members of the RAD6 epistasis group have reasonably conserved orthologs in mammals (2, 20, 35). Therefore, the checkpoint-dependent regulation of posttranscriptional control pathways may be not be restricted to yeast but may also contribute to the prevention of chromosome aberrations in mammalian cells.

    ACKNOWLEDGEMENTS

We thank Matthew O'Connell for help with tetrad dissections; Tony Tiganis for help with flow cytometry; Lindus Conlan for advice on two-hybrid screens; and Steve Dalton, Matthew O'Connell, Andy Poumbourios, and Tony Tiganis for critically reading the manuscript.

    FOOTNOTES

* This work was supported by grants from the National Health and Medical Research Council (NHMRC) of Australia and the Anti-Cancer-Council of Victoria (ACCV) (to J. H.), Australian postgraduate awards (to A. H. and B. L. P.), an ACCV postdoctoral fellowship (to A. H.), and an NHMRC senior research fellowship (to J. H.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed. Tel.: 61-3-9288-2480; Fax: 61-3-9416-2676; E-mail: heier@ariel.its.unimelb.edu.au.

Published, JBC Papers in Press, April 12, 2002, DOI 10.1074/jbc.M202473200

    ABBREVIATIONS

The abbreviations used are: FHA, forkhead-associated; PAN, poly(A)-nuclease; HA, hemagglutinin; HU, hydroxyurea; MMS, methyl methanesulfonate; RNR, ribonucleotide reductase; YPD, yeast extract/peptone/glucose.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Zhou, B. B., and Elledge, S. J. (2000) Nature 408, 433-439[CrossRef][Medline] [Order article via Infotrieve]
2. Matsuoka, S., Huang, M., and Elledge, S. J. (1998) Science 282, 1893-1897[Abstract/Free Full Text]
3. Brown, A. L., Lee, C. H., Schwarz, J. K., Mitiku, N., Piwnica-Worms, H., and Chung, J. H. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 3745-3750[Abstract/Free Full Text]
4. Bell, D. W., Varley, J. M., Szydlo, T. E., Kang, D. H., Wahrer, D. C., Shannon, K. E., Lubratovich, M., Verselis, S. J., Isselbacher, K. J., Fraumeni, J. F., Birch, J. M., Li, F. P., Garber, J. E., and Haber, D. A. (1999) Science 286, 2528-2531[Abstract/Free Full Text]
5. Li, J., Lee, G., Van Doren, S. R., and Walker, J. C. (2000) J. Cell Sci. 113, 4143-4149[Abstract]
6. Sun, Z., Hsiao, J., Fay, D. S., and Stern, D. F. (1998) Science 281, 272-274[Abstract/Free Full Text]
7. Liao, H., Byeon, I. J., and Tsai, M. D. (1999) J. Mol. Biol. 294, 1041-1049[CrossRef][Medline] [Order article via Infotrieve]
8. Liao, H., Yuan, C., Su, M. I., Yongkiettrakul, S., Qin, D., Li, H., Byeon, I. J., Pei, D., and Tsai, M. D. (2000) J. Mol. Biol. 304, 941-951[CrossRef][Medline] [Order article via Infotrieve]
9. Durocher, D., Taylor, I. A., Sarbassova, D., Haire, L. F., Westcott, S. L., Jackson, S. P., Smerdon, S. J., and Yaffe, M. B. (2000) Mol. Cell 6, 1169-1182[CrossRef][Medline] [Order article via Infotrieve]
10. Zhou, Z., and Elledge, S. J. (1993) Cell 75, 1119-1127[CrossRef][Medline] [Order article via Infotrieve]
11. Pati, D., Keller, C., Groudine, M., and Plon, S. E. (1997) Mol. Cell. Biol. 17, 3037-3046[Abstract]
12. Gardner, R., Putnam, C. W., and Weinert, T. (1999) EMBO J. 18, 3173-3185[CrossRef][Medline] [Order article via Infotrieve]
13. Myung, K., Datta, A., and Kolodner, R. D. (2001) Cell 104, 397-408[CrossRef][Medline] [Order article via Infotrieve]
14. Fasullo, M., Koudelik, J., AhChing, P., Giallanza, P., and Cera, C. (1999) Genetics 152, 909-919[Abstract/Free Full Text]
15. Navas, T. A., Zhou, Z., and Elledge, S. J. (1995) Cell 80, 29-39[CrossRef][Medline] [Order article via Infotrieve]
16. Huang, M., Zhou, Z., and Elledge, S. J. (1998) Cell 94, 595-605[CrossRef][Medline] [Order article via Infotrieve]
17. Tucker, M., and Parker, R. (2000) Annu. Rev. Biochem. 69, 571-595[CrossRef][Medline] [Order article via Infotrieve]
18. Otero, L. J., Ashe, M. P., and Sachs, A. B. (1999) EMBO J. 18, 3153-3163[CrossRef][Medline] [Order article via Infotrieve]
19. Fortes, P., Inada, T., Preiss, T., Hentze, M. W., Mattaj, I. W., and Sachs, A. B. (2000) Mol. Cell 6, 191-196[CrossRef][Medline] [Order article via Infotrieve]
20. Tucker, M., Valencia-Sanchez, M. A., Staples, R. R., Chen, J., Denis, C. L., and Parker, R. (2001) Cell 104, 377-386[CrossRef][Medline] [Order article via Infotrieve]
21. Moser, M. J., Holley, W. R., Chatterjee, A., and Mian, I. S. (1997) Nucleic Acids Res. 25, 5110-5118[Abstract/Free Full Text]
22. Brown, C. E., and Sachs, A. B. (1998) Mol. Cell. Biol. 18, 6548-6559[Abstract/Free Full Text]
23. James, P., Halladay, J., and Craig, E. A. (1996) Genetics 144, 1425-1436[Abstract]
24. Winzeler, E. A., Shoemaker, D. D., Astromoff, A., Liang, H., Anderson, K., Andre, B., Bangham, R., Benito, R., Boeke, J. D., Bussey, H., Chu, A. M., Connelly, C., Davis, K., Dietrich, F., Dow, S. W., El, Bakkoury, M., Foury, F., Friend, S. H., Gentalen, E., Giaever, G., Hegemann, J. H., Jones, T., Laub, M., Liao, H., et al.. (1999) Science 285, 901-906R[Abstract/Free Full Text]. W.
25. Pike, B. L., Hammet, A., and Heierhorst, J. (2001) J. Biol. Chem. 276, 14019-14026[Abstract/Free Full Text]
26. Zhao, X., Muller, E. G., and Rothstein, R. (1998) Mol. Cell 2, 329-340[CrossRef][Medline] [Order article via Infotrieve]
27. Mumberg, D., Müller, R., and Funk, M. (1994) Nucleic Acids Res. 22, 5767-5768[Free Full Text]
28. Hammet, A., Pike, B. L., Mitchelhill, K. I., Teh, T., Kobe, B., House, C. M., Kemp, B. E., and Heierhorst, J. (2000) FEBS Lett. 471, 141-146[CrossRef][Medline] [Order article via Infotrieve]
29. Brown, C. E., Tarun, S. Z., Boeck, R., and Sachs, A. B. (1996) Mol. Cell. Biol. 16, 5744-5753[Abstract]
30. Tanaka, K., and Russell, P. (2001) Nat. Cell Biol. 3, 966-972[CrossRef][Medline] [Order article via Infotrieve]
31. Hartman, J. L. I., Garvik, B., and Hartwell, L. (2001) Science 291, 1001-1004[Abstract/Free Full Text]
32. Sanchez, Y., Desany, B. A., Jones, W. J., Liu, Q., Wang, B., and Elledge, S. J. (1996) Science 271, 357-360[Abstract]
33. Jensen, T. H., Patricio, K., McCarthy, T., and Rosbash, M. (2001) Mol. Cell 7, 887-898[CrossRef][Medline] [Order article via Infotrieve]
34. Xiao, W., Chow, B. L., Broomfield, S., and Hanna, M. (2000) Genetics 155, 1633-1641[Abstract/Free Full Text]
35. Ulrich, H. D., and Jentsch, S. (2000) EMBO J. 19, 3388-3397[CrossRef][Medline] [Order article via Infotrieve]
36. Brusky, J., Zhu, Y., and Xiao, W. (2000) Curr. Genet. 37, 168-174[CrossRef][Medline] [Order article via Infotrieve]
37. Olivas, W., and Parker, R. (2000) EMBO J. 19, 6602-6611[CrossRef][Medline] [Order article via Infotrieve]
38. Datta, A., Schmeits, J. L., Amin, N. S., Lau, P. J., Myung, K., and Kolodner, R. D. (2000) Mol. Cell 6, 593-603[CrossRef][Medline] [Order article via Infotrieve]
39. Bashkirov, V. I., King, J. S., Bashkirova, E. V., Schmuckli-Maurer, J., and Heyer, W. D. (2000) Mol. Cell. Biol. 20, 4393-4404[Abstract/Free Full Text]
40. Denis, C. L., Chiang, Y.-C., Cui, Y., and Chen, J. (2001) Genetics 158, 627-634[Abstract/Free Full Text]
41. Moriya, H., Shimizu-Yoshida, Y., Omori, A., Iwashita, S., Katoh, M., and Sakai, A. (2001) Genes Dev. 15, 1217-1228[Abstract/Free Full Text]
42. Kleimann, F. E., and Manley, J. L. (2001) Cell 104, 743-753[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
RNAHome page
T. H. Beilharz and T. Preiss
Widespread use of poly(A) tail length control to accentuate expression of the yeast transcriptome
RNA, July 1, 2007; 13(7): 982 - 997.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
F. G. Rucker, L. Bullinger, C. Schwaenen, D. B. Lipka, S. Wessendorf, S. Frohling, M. Bentz, S. Miller, C. Scholl, R. F. Schlenk, et al.
Disclosure of Candidate Genes in Acute Myeloid Leukemia With Complex Karyotypes Using Microarray-Based Molecular Characterization
J. Clin. Oncol., August 20, 2006; 24(24): 3887 - 3894.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
A. Traven, A. Hammet, N. Tenis, C. L. Denis, and J. Heierhorst
Ccr4-Not Complex mRNA Deadenylase Activity Contributes to DNA Damage Responses in Saccharomyces cerevisiae
Genetics, January 1, 2005; 169(1): 65 - 75.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. L. Pike, N. Tenis, and J. Heierhorst
Rad53 Kinase Activation-independent Replication Checkpoint Function of the N-terminal Forkhead-associated (FHA1) Domain
J. Biol. Chem., September 17, 2004; 279(38): 39636 - 39644.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
K. L. Schollaert, J. M. Poisson, J. S. Searle, J. A. Schwanekamp, C. R. Tomlinson, and Y. Sanchez
A Role for Saccharomyces cerevisiae Chk1p in the Response to Replication Blocks
Mol. Biol. Cell, September 1, 2004; 15(9): 4051 - 4063.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
B. L. Pike, S. Yongkiettrakul, M.-D. Tsai, and J. Heierhorst
Mdt1, a Novel Rad53 FHA1 Domain-Interacting Protein, Modulates DNA Damage Tolerance and G2/M Cell Cycle Progression in Saccharomyces cerevisiae
Mol. Cell. Biol., April 1, 2004; 24(7): 2779 - 2788.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Uchida, S.-i. Hoshino, and T. Katada
Identification of a Human Cytoplasmic Poly(A) Nuclease Complex Stimulated by Poly(A)-binding Protein
J. Biol. Chem., January 9, 2004; 279(2): 1383 - 1391.
[Abstract] [Full Text] [PDF]